Article Text

Download PDFPDF
Dominant Epstein–Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding TD is supported by the FAG (‘Freiwillige Akademische Gesellschaft’) of Basel and by an EULAR bursary, CH by the Swiss National Science Foundation (SNSF) (PP00B-114850).

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval This study was conducted with the approval of the Ethik Komission beider Basel.

  • Provenance and peer review Not commissioned; externally peer reviewed.